Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Discontinuation therapy with intravenous methylprednisolone and diazepam in chronic migraine with medication overuse
2017-004606-18Phase 3Completed
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of methylprednisolone and diazepam in chronic migraine and medication overuse headache (MOH), sponsored by Università Campus Bio-Medico di Roma. Started Oct 2021; status: completed.
02
Drugs
methylprednisolonediazepam
03
Conditions
chronic migrainemedication overuse headache (MOH)
Beyond the preview
Go deeper on 2017-004606-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004606-18.